Skip to navigation bar Skip to breadcrumbs Skip to page content
Envelope icon E-mail Updates Teal square Text size:  a A A
You are here: HomeAnnouncementsAnnouncement Detail

Final Research Plan: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality

September 26, 2019–The U.S. Preventive Services Task Force posted today a final research plan on aspirin use to prevent preeclampsia and related morbidity and mortality. The draft research plan for this topic was posted for public comment from June 20, 2019 to July 17, 2019. The Task Force reviewed all of the comments that were submitted and took them into consideration as it finalized the research plan. To view the final research plan, please go here.

Current as of: October 2019

Internet Citation: Final Research Plan: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality. U.S. Preventive Services Task Force. September 2019.
https://www.uspreventiveservicestaskforce.org/Announcements/News/Item/final-research-plan-aspirin-use-to-prevent-preeclampsia-and-related-morbidity-and-mortality

USPSTF Program Office   5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857